Forefront Analytics, Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$110.0M
Q ending 2026-03-31
Prior quarter
$113.3M
Q ending 2025-12-31
Change
-2.9% QoQ · +26.5% YoY
Positions
39
reported holdings

Largest positions

All 39 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Ishares TrESGDShares$24.3M254K
Ishares IncESGEShares$16.8M369K
Vanguard Intl Equity Index FVWOShares$9.7M180K
Ishares TrHDVShares$9.2M68K
Nushares Etf TrNULVShares$8.9M196K
Flexshares TrESGGShares$8.8M44K
Dbx Etf TrDBEFShares$6.3M127K
Ishares TrMTUMShares$5.8M24K
Vanguard Tax-Managed FdsVEAShares$3.0M47K
Ishares TrIVVShares$2.9M4K
Nvidia CorporationNVDAShares$2.5M14K
Ishares IncHEEMShares$2.2M59K
Jpmorgan Chase & CoJPMShares$1.5M5K
Deere & CoDEShares$640K1K
Unitedhealth Group IncUNHShares$537K2K
Edwards Lifesciences CorpEWShares$526K7K
Abbott LaboratoriesABTShares$518K5K
Wisdomtree TrEESShares$478K8K
Schwab Strategic TrSCHDShares$464K15K
Medtronic PlcShares$461K5K
Proshares TrSSOShares$424K8K
Incyte CorpINCYShares$398K4K
Proshares TrUWMShares$373K8K
Pfizer IncPFEShares$368K13K
Blue Owl Technology Fin CorpOTFShares$367K30K
Regeneron PharmaceuticalsREGNShares$355K460
Thermo Fisher Scientific IncTMOShares$285K579
Legend Biotech CorpLEGNShares$283K16K
Vanguard Index FdsVTVShares$258K1K
Danaher Corp DelDHRShares$244K1K
Philip Morris Intl IncPMShares$240K1K
Dimensional Etf TrustDFSVShares$222K6K
Nkarta IncNKTXShares$92K44K
Zura Bio LtdShares$89K15K
Geron CorpGERNShares$82K55K
Annexon IncANNXShares$79K14K
Bicycle Therapeutics PlcBCYCShares$67K14K
Cytomx Therapeutics Inc.CTMXShares$59K12K
Mereo Biopharma Group PlcMREOShares$42K128K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.